Scientists from Intermountain Medical Center found routine periodic fasting is associated with a lower risk for hospitalization or death in patients with COVID-19.
The research is published in BMJ Nutrition, Prevention & Health and was conducted by Benjamin D. Horne et al.
In the study, researchers evaluated associations between periodic fasting and COVID-19 severity, as well as initial infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The analysis included 205 people who tested positive for SARS-CoV-2 from March 2020 to February 2021 and 1,524 with any SARS-CoV-2 test result.
The researchers found that 35.6 percent of participants engaged in periodic fasting prior to the COVID-19 diagnosis.
The composite outcome (COVID-19 hospitalization or mortality) occurred in 11.0 percent of periodic fasters and 28.8 percent of non-fasters.
Predictors of hospitalization and mortality were age, Hispanic ethnicity, prior myocardial infarction, prior transient ischemic attack, and renal failure.
There was no strong association between fasting and COVID-19 diagnosis (14.3 percent in fasters and 13.0 percent in non-fasters).
The team says fasting may be a complementary therapy to vaccination that could provide immune support and hyperinflammation control during and beyond the pandemic.
If you care about Covid, please read studies about the root causes of severe COVID-19, and Vitamin D3 could help people fight against COVID-19.
For more information about Covid, please see recent studies that shark stuff could fight COVID-19 virus, and results showing this common drug could almost halve COVID-19 death risk.
Copyright © 2022 Knowridge Science Report. All rights reserved.